Resources Contact Us Home
Purine derivatives as A3 and A1 adenosine receptor agonists

Image Number 5 for United States Patent #7825126.

Disclosed are (N)-methanocarba adenine nucleosides of the formula: ##STR00001## as highly potent A.sub.3 adenosine receptor agonists, pharmaceutical compositions comprising such nucleosides, and a method of use of these nucleosides, wherein R.sub.1-R.sub.6 are as defined in the specification. These nucleosides are contemplated for use in the treatment a number of diseases, for example, inflammation, cardiac ischemia, stroke, asthma, diabetes, and cardiac arrhythmias. The invention also provides compounds that are agonists of both A.sub.1 and A.sub.3 adenosine receptors for use in cardioprotection.

  Recently Added Patents
System and method for text input with a multi-touch screen
Carrying case
Method and system for video parameter analysis and transmission
Redundant power delivery
Clusterin antisense therapy for treatment of cancer
System, method, and computer program product for identifying unwanted data communicated via a session initiation protocol
Respirator belt having bumper cushion
  Randomly Featured Patents
Seismic prospecting using a continuous shooting and continuous recording system
Slot machine game and system with improved jackpot feature
Repeater module
Automatic mechanically controlled continuously-variable-ratio drive
Method and apparatus for reformation of fuels at low temperatures
Method for detecting the viability of trichuris suis eggs
Contoured seat and method
Medical shunt/valve for regulation of bodily fluids